Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

July 31, 2006

Conditions

HyperemiaHypoxia

Interventions

DRUG

dipyridamole

DRUG

caffeine

Trial Locations (1)

Radboud university Nijmegen Medical Centre, Nijmegen

All Listed Sponsors

lead

Radboud University Medical Center

OTHER

NCT00268554 - Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole | Biotech Hunter | Biotech Hunter